FDA Approves Actemra for the Treatment of COVID-19 in Hospitalized Adults

NewsDesk @bactiman63 Genentech today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra(R) (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). Actemra is the first FDA-approved monoclonal antibody to treat [...]

The post FDA Approves Actemra for the Treatment of COVID-19 in Hospitalized Adults appeared first on Outbreak News Today.